Projects per year
Abstract
Cardiovascular disease is the leading cause of death in the Western world. The incidence of cardiovascular disease is predicted to further rise with the increase in obesity and diabetes and with the aging population. Even though the survival rate from ischaemic heart disease has improved over the past 30 years, many patients progress to a chronic pathological condition, known as cardiac hypertrophy that is associated with an increase in morbidity and mortality. Reactive oxygen species (ROS) and calcium play an essential role in mediating cardiac hypertrophy. The L-type calcium channel is the main route for calcium influx into cardiac myocytes. There is now good evidence for a direct role for the L-type calcium channel in the development of cardiac hypertrophy. Cysteines on the channel are targets for redox modification and glutathionylation of the channel can modulate the function of the channel protein leading to the onset of pathology. The cysteine responsible for modification of L-type calcium channel function has now been identified. Detailed understanding of the role of cysteines as possible targets during oxidative stress may assist in designing therapy to prevent the development of hypertrophy and heart failure.
Original language | English |
---|---|
Pages (from-to) | 46-54 |
Number of pages | 9 |
Journal | Clinical and Experimental Pharmacology and Physiology |
Volume | 44 |
DOIs | |
Publication status | Published - 1 Dec 2017 |
Fingerprint
Dive into the research topics of 'The cardiac L-type calcium channel alpha subunit is a target for direct redox modification during oxidative stress—the role of cysteine residues in the alpha interacting domain'. Together they form a unique fingerprint.Projects
- 3 Finished
-
NHMRC Research Fellowships - Hool
Hool, L. (Investigator 01)
NHMRC National Health and Medical Research Council
1/01/11 → 31/12/16
Project: Research
-
Identifying the Sites of Modification on the Human L-type Ca2+ Channel Protein Isoforms During Oxidative Stress with Reference to Development of a Therpeutic Target
Hool, L. (Investigator 01), Ingley, E. (Investigator 02) & Corry, B. (Investigator 03)
NHMRC National Health and Medical Research Council
1/01/11 → 31/12/13
Project: Research
-
Determining how Calcium Regulates Mitochondrial Function in Models of Cardiomyopathy.
Hool, L. (Investigator 01)
ARC Australian Research Council
1/01/10 → 31/12/14
Project: Research